Want to see MTD full AI Analyst Report?
Mettler-Toledo (MTD) Q2 2026 Earnings Report
MTD Q2 2026 EPS Results
- Actual EPS
- $11.46
- Consensus EPS
- $10.85
- Beat/Miss
- Beat by +$0.61
- One Year Ago EPS
- $10.09
MTD Q2 2026 Revenue Results
- Actual Revenue
- $1.03B
- Expected Revenue
- $1.03B
- Beat/Miss
- Missed by -$431.00K
- YoY Revenue Growth
- +4.48%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/30/2026
- Time
- After Close
- Conference Call
- Thursday, July 30, 2026
Mettler-Toledo's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
The call conveyed a decidedly positive operational and financial picture: revenue growth beat expectations, margins expanded, adjusted EPS rose ~14% and full-year guidance was raised. Strength was broad-based (China, emerging markets, Lab, Industrial automation, services) and driven by pricing, productivity initiatives (Spinnaker) and product innovation. Notable risks and noise included one-time tariff refund accounting that reduced reported sales, timing-related weakness in Product Inspection and certain projects, EU chemical exposure to energy costs, higher transportation costs, and short backlog that increases near-term sensitivity. On balance, management presented confidence in execution and raised guidance, indicating momentum into the second half despite identifiable near-term risks.
The company raised its full‑year 2026 guidance, now calling for local‑currency sales growth of approximately 4%–5% (organic 3%–4%) excluding the one‑time tariff refunds, with adjusted EPS guidance of $47.15–$47.50 (up ~10%–11%, or ~11%–12% excluding currency); at recent spot rates FX is estimated to be a ~1% benefit to sales and a slight headwind to EPS. For Q3 2026 the company expects local‑currency sales growth of ~4% (including ~0.5% from acquisitions) and adjusted EPS of $12.00–$12.15 (up ~8%–9%, or ~9%–10% excluding currency); currency is expected to be neutral to Q3 sales and a ~1% headwind to Q3 EPS. Additional 2026 assumptions: total amortization ~$78M (purchased intangibles ~$28M pretax, ≈$1.07), interest expense ~$67M, other income ~$24M, effective tax rate ~19%, free cash flow ~ $900M (≈6% growth per share), and share repurchases increased to $875M for the year (vs. $825M annualized in H1).
- Top-Line Growth Outperformed ExpectationsQ2 sales were $1.0B, up 7% in USD and 6% in local currency; organic local-currency sales growth was 4% and acquisitions contributed ~1.5%.
- Strong Regional Performance — China and Emerging MarketsAsia/Rest of World organic growth was +9% (China +9%); emerging markets outside China represented ~18% of sales and grew high single digits in the quarter.
- Broad-Based Product Strength — Lab, Industrial, Food Retail, ServiceLaboratory organic sales +4%; Core Industrial +4% (Industrial overall +3%); Food Retail +11%; Service revenue +9% (7% organically), with service continuing to outgrow product sales.
- Margin Expansion and ProfitabilityAdjusted gross margin 59.3% (up 30 bps); excluding FX and acquisitions gross margin expanded ~90 bps. Adjusted operating margin 29.3% (up 50 bps vs prior year; +100 bps excluding currency).
- Earnings Per Share and Operating Profit GrowthAdjusted operating profit $309M (+9% YoY). Adjusted EPS $11.46 (+14% YoY). Reported EPS $11.55 vs $9.76 a year ago (reported included one-time tariff impacts).
- Raised Full-Year GuidanceFull-year local-currency sales growth increased to ~4–5% (organic 3–4%). Adjusted EPS guidance raised to $47.15–$47.50 (10–11% growth; 11–12% ex-currency), up from prior 8–10% range.
- Solid Cash Flow and Capital Return PlansAdjusted free cash flow YTD $367M; full-year free cash flow expected ~ $900M (~6% per-share growth). Share repurchases increased to $875M for the full year (vs $825M annualized first half).
- Execution Drivers — Spinnaker, Productivity and InnovationManagement cites Spinnaker sales/marketing program, productivity initiatives and recent product innovation (e.g., LabX, new balances, pipettes) as key drivers of growth, pricing power (~3% price realization in Q2) and margin expansion.
MTD Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | 12.12- | 11.15 | ― | ― |
| Jul 30, 2026 | 2026 (Q2) | 10.8511.46 | 10.09 | 13.58% (+1.37) | |
| May 07, 2026 | 2026 (Q1) | 8.718.91 | 8.19 | 8.79% (+0.72) | |
| Feb 05, 2026 | 2025 (Q4) | 12.8013.36 | 12.41 | 7.66% (+0.95) | |
| Nov 06, 2025 | 2025 (Q3) | 10.6611.15 | 10.21 | 9.21% (+0.94) | |
| Jun 30, 2025 | 2025 (Q2) | 9.6010.09 | 9.65 | 4.56% (+0.44) | |
| May 01, 2025 | 2025 (Q1) | 7.888.19 | 8.89 | -7.87% (-0.70) | |
| Feb 06, 2025 | 2024 (Q4) | 11.7212.41 | 9.4 | 32.02% (+3.01) | |
| Nov 07, 2024 | 2024 (Q3) | 10.0110.21 | 9.8 | 4.18% (+0.41) | |
| Aug 01, 2024 | 2024 (Q2) | 9.039.65 | 10.19 | -5.30% (-0.54) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
